Knowledge Hub

Research, Publications & Presentations

AMP Discovery Logo
Menu

Latest Reports

Downloadable Reports With Information Related To The Industry

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat...

Downloadable Reports With Information Related To The Industry

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat...

Downloadable Reports With Information Related To The Industry

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat...

Downloadable Reports With Information Related To The Industry

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat...

Publications

As knowledge in this new industry continues to grow, we will keep you up to date with the latest news and groundbreaking studies that will aid in our pursuit for a healthier tomorrow.

Published 2019
Design of Novel Amphipathic α-Helical Antimicrobial Peptides with No Toxicity as Therapeutics against the Antibiotic-Resistant Gram-Negative Bacterial Pathogen, Acinetobacter Baumannii
Colin T Mant, Ziqing Jiang, Lajos Gera, Tim Davis, and Robert S Hodges
Published 2019
De novo Designed Amphipathic α-helical Antimicrobial Peptides Incorporating Dab and Dap Residues on the Polar Face to Treat the Gram-Negative Pathogen, Acinetobacter baumannii.
C.T. Mant, Z. Jiang, L. Gera, T. Davis, K.L. Nelson, S. Bevers and R.S. Hodges.
Published 2018
Role of Positively Charged Residues on the Polar and Non-polar Faces of Amphipathic α-Helical Antimicrobial Peptides on Specificity and Selectivity for Gram-negative Pathogens.
Z. Jiang, C.T. Mant, M. Vasil and R.S. Hodges.
Published 2015
Design of New Antimicrobial Peptides (AMPs) with “Specificity Determinants” that Encode Selectivity for Gram-negative Pathogens and Remove both Gram-positive Activity and Hemolytic Activity from Broad-spectrum AMPs.
Z. Jiang, L. Gera, C.T. Mant and R.S. Hodges.
Published 2014
“Specificity Determinants” Improve Therapeutic Indices of Two Antimicrobial Peptides Piscidin 1 and Dermaseptin S4 Against the Gram-negative Pathogens Acinetobacter baumannii and Pseudomonas aeruginosa.
Z. Jiang, A.L. Vasil, M.L. Vasil and R.S. Hodges.
Published 2011
Rational Design of α-Helical Antimicrobial Peptides to Target Gram-negative Pathogens, Acinetobacter baumannii and Pseudomonas aeruginosa: Utilization of Charge, “Specficity Determinants,” Total Hydrophobicity, Hydrophobe Type and Location as Design Parameters to Improve the Therapeutic Ratio
Z. Jiang, A.I. Vasil, L. Gera, M.L. Vasil and R.S. Hodges.

Events & Presentations

June 10-13, 2019
IC2AR 2019: 3rd International Caparica Congress in Antibiotic Resistance
Caparica, Portugal

Invited keynote speakers Dr. Robert Hodges gave presentation: “On the Road to Commercialization of Antimicrobial Peptides to Treat Gram-negative Bacterial Infections”.

June 22-27, 2019
26th American Peptide Symposium and the 11th International Peptide Symposium
Monterey, CA

Poster presentation by C.T. Mant, Z. Jiang, L. Gera, T. Davis, K.L. Nelson, S. Bevers and R.S. Hodges: “On the Road to Commercialization of Antimicrobial Peptides to Treat Gram-negative Bacterial Infections”.

July 10-12, 2019
ISPPP 2019: 39th International Symposium and Exhibit on the Separation, Purification and Characterization of Biologically Important Molecules
Baltimore, MD

Lecture by Dr. Robert Hodges and poster by C.T. Mant, Z. Jiang, L. Gera, T. Davis and R.S. Hodges: "De novo Designed Antimicrobial Peptides are Effective against Antibiotic Resistant Gram-negative Organisms".

SEPTEMBER 20, 2019
Peptide Conference: Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd.
Jiangyin, Jiangsu, China

Designing Alpha-Helical Antimicrobial Peptides with no Toxicity as New Therapeutics to Target Gram-Negative Pathogens Resistant to Antibiotics of Last Resort

September 23-26, 2019
Boulder Peptide Symposium
Boulder, CO

Presentation by Dr. Robert Hodges: “On the Road to Commercialization of Antimicrobial Peptides to Treat Gram-negative Bacterial Infections”.

Contact Us
X
AMP Discovery Logo